Fred Alger Management, LLC Uni Qure N.V. Transaction History

Fred Alger Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$40.01 - $73.97 $280,070 - $517,790	-7,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $259,910 - $522,340	7,000 New	7,000 $502,000
Q3 2019 Nov 14, 2019	SELL	$39.36 - $76.8 $413,280 - $806,400	-10,500 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $553,980 - $862,995	10,500 New	10,500 $821,000
Q3 2018 Nov 14, 2018	SELL	$29.75 - $43.08 $773,500 - $1.12 Million	-26,000 Closed	0 $0
Q2 2018 Jul 19, 2018	BUY	$21.96 - $39.94 $570,960 - $1.04 Million	26,000 New	26,000 $983,000

154

41M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $280M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.